PsyMed

Get funding

PsyMed is an entrepreneur-led VC fund that focuses on transformational technologies that boost mental health and wellness to help solve the current mental health crisis.

Use: R&D; Go2Market;
Date closing: -
Amount: -
Industry focus: Health;
Total budget: 25M €
Entity type: Venture Capital
Vertical focus: psychedelic medicine, precision psychiatry, neurotechnology, biotech, digital therapeutics, human augmentation
Website: https://psymed.ventures/

Status:
Open
Funding type: Grant; Equity investment;
Geographic focus:
Public/Private: Public
Stage focus: pre-seed; Seed; Series A;
Applicant target: Startup;

Add a Review Send question

Overview

PsyMed’s main objective is to provide capital and support to the best and most innovative companies that combine healing, responsibility, and profitability. Within the fields they invest in, they put special attention to psychedelic medicine & new compounds, precision psychiatry, neurotech & human augmentation, and digital therapeutics.

They intend to provide capital and resources in order to work on problems extremely difficult to solve with a small number of people willing to fund, but which can bring a positive change to humanity.

The new fund raises to $25 million, however, for further information about the application process and the fund, candidates must contact PsyMed via email: [email protected]

Portfolio: Terran biosciences, Tripp, Maya, Atai.

Last update: March 23, 2022.

Last updated on 2022-03-23 09:28